UK - UK pension fund for pharmaceuticals giant Roche - which has just replaced its consultants Hewitt Bacon & Woodrow with rivals Watson Wyatt - is likely to ditch Merrill Lynch Investment Managers in a move that could spark an overhaul of its entire £400m portfolio.
A scheme source said the fund was not satisfied with Merrill's performance and that Roche was unlikely to retain the firm following a trustee meeting in July. Currently, Merrill handles £200m in...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
